TCRs expressed by Vδ2 T cells preferentially couple with the Vδ2 and Vγ9 chains and directly target tumor cells via perforin and granzyme or indirectly target these cells through the release of IFN-γ and TNF-α [21, 34]. This evidence concerns the gene IFNG and neoplasm.